Methods for promoting weight gain using GPE-related compounds
US6682753B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Mar 13, 2002 |
| Grant date | Jan 27, 2004 |
| Priority date | — |
| Expiry date | Mar 13, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0819
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Weight gain in a mammal, especially a human, having a condition that leads to decreased weight gain or weight loss, such as AIDS, brain trauma, a chronic neurodegenerative disease such as Alzheimer's disease, Parkinson's disease, Huntington's disease, or multiple sclerosis, or other condition, is promoted by increasing the effective concentration of a GPE-related compound (GPE or a GPE analog) in the central nervous system of the mammal. This increase may be achieved by administration to the mammal of an effective amount of a GPE-related compound, a prodrug thereof, or an implant containing cells that express the GPE-related compound or prodrug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.